Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher
18 June 2024 - 2:40AM
AllPennyStocks.com
Imagine a new weapon in the fight against cancer, a personalized
therapy that utilizes the body's own immune system to attack
tumors. Science fiction? This biotech company just secured
exclusive...
To read the full story on AllPennyStocks.com, click
here.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Jan 2025 to Feb 2025
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Feb 2024 to Feb 2025